- Condition: Tinnitus
Intervention: Device: Bimodal Repetitive Transcranial Magnetic Stimulation
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Not yet recruiting - verified April 2012 - Conditions: Blast Injuries; Brain Injuries; Age Factors
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Not yet recruiting - verified March 2012 - Condition: Autoimmune Inner Ear Disease
Intervention: Drug: Golimumab
Sponsors: House Research Institute; House Research Institute; Janssen Services, LLC
Recruiting - verified March 2012 - Condition: Hearing Loss, Sensorineural
Interventions: Drug: PF-04958242; Drug: PF-04958242; Drug: Placebo
Sponsors: Pfizer; Pfizer
Recruiting - verified May 2012 - Conditions: Retinitis Pigmentosa; Usher Syndrome Type 2; Usher Syndrome Type 3
Intervention: Drug: NT-501 in study eye and sham surgery in contralateral eye
Sponsors: Neurotech Pharmaceuticals; Neurotech Pharmaceuticals; University of California, San Francisco
Recruiting - verified February 2012 - Condition: Donnai Barrow Syndrome
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified January 2012 - Conditions: Usher Syndrome; Retinitis Pigmentosa
Intervention: Genetic: UshStat
Sponsors: Oxford BioMedica; Oxford BioMedica
Recruiting - verified February 2012 - Condition: Tinnitus
Interventions: Other: Customized sound; Other: Regular Masker
Sponsors: University of California, Irvine; University of California, Irvine
Recruiting - verified December 2011 - Condition: Tinnitus
Interventions: Other: Sound Based and Educational Therapies; Other: Integrated Medicine Therapies and Sound Based Education Therapies; Other: Integrated Medicine Therapies and SBE
Sponsors: Duke University; Duke University; National Institutes of Health (NIH); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified November 2011 - Condition: Hearing Loss
Intervention: Procedure: Percutaneous Cochlear Implantation
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified October 2011 - Condition: Noise-induced Hearing Loss
Interventions: Behavioral: Sampler of hearing protection devices; Behavioral: Static Web-based information; Behavioral: Interactive Web-based information
Sponsors: University of Michigan; Marjorie McCullagh; National Institutes of Health (NIH)
Recruiting - verified April 2012 - Conditions: Lung Cancer; Head and Neck Cancer; Hearing Loss; Ototoxicity; Tinnitus; Neuropathy
Interventions: Drug: SPI-1005 Low Dose; Drug: SPI-1005 Middle dose; Drug: SPI-1005 High Dose; Drug: Placebo
Sponsors: Sound Pharmaceuticals, Incorporated; Sound Pharmaceuticals, Incorporated; VA Puget Sound Health Care System
Not yet recruiting - verified October 2011 - Condition: Tinnitus
Intervention: Behavioral: Brain Fitness Program - Tinnitus
Sponsors: Washington University School of Medicine; Washington University School of Medicine; Federal Emergency Management Agency
Recruiting - verified April 2012 - Conditions: Single Sided Deafness; Conductive Hearing Loss
Intervention:
Sponsors: Sonitus Medical Inc; Sonitus Medical Inc
Recruiting - verified April 2012 - Condition: Temporary Auditory Threshold Shift
Interventions: Drug: SPI-1005 Low dose; Drug: SPI-1005 Middle dose; Drug: SPI-1005 High dose; Drug: Placebo
Sponsors: Sound Pharmaceuticals, Incorporated; Sound Pharmaceuticals, Incorporated; University of Florida
Recruiting - verified October 2011 - Condition: Cancer
Interventions: Procedure: Insertion of Pressure Equalization (PE) Tubes; Drug: Sodium Thiosulfate (STS); Other: Saline (Placebo); Drug: Cisplatin
Sponsors: Thomas Jefferson University; Thomas Jefferson University
Recruiting - verified January 2012 - Condition: Noise-Induced Hearing Loss
Interventions: Drug: D-methionine, oral liquid suspension; Other: Placebo Comparator
Sponsors: Southern Illinois University; Southern Illinois University; Department of Defense
Not yet recruiting - verified February 2012 - Conditions: Neurofibromatosis Type 2; Neuroma, Acoustic
Intervention: Drug: RAD001, everolimus
Sponsors: House Research Institute; House Research Institute; Novartis Pharmaceuticals
Not yet recruiting - verified January 2012 - Conditions: Tinnitus; Traumatic Brain Injury; Post Traumatic Stress Disorder
Intervention:
Sponsors: Washington University School of Medicine; Washington University School of Medicine; Department of Defense
Not yet recruiting - verified April 2012 - Conditions: Sensorineural Hearing Loss; Autoimmune Inner Ear Disease
Intervention: Drug: Anakinra
Sponsors: North Shore Long Island Jewish Health System; North Shore Long Island Jewish Health System; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified August 2011 - Condition: Tinnitus
Interventions: Dietary Supplement: Magnesium; Other: Placebo
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified February 2012 - Condition: Tinnitus
Intervention: Drug: AM-101
Sponsors: Auris Medical, Inc.; Auris Medical, Inc.
Recruiting - verified March 2012 - Conditions: Aging; Hearing Loss
Intervention:
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Conditions: Deafness; Hearing Loss
Interventions: Device: cochlear implantation; Device: hearing aids
Sponsors: Stanford University; Stanford University; Baylor College of Medicine
Recruiting - verified July 2011 - Conditions: Vestibular Schwannoma; Acoustic Neuroma
Intervention: Radiation: Fractionated proton radiation
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Condition: Hearing Loss, Sensorineural
Intervention: Drug: Fludrocortisone
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified August 2011 - Condition: Subjective Tinnitus
Interventions: Device: Conventional sound generator (SG); Device: Placebo sound generator (placebo SG); Behavioral: Standard of Care (SC); Behavioral: Directive Counseling (DC); Behavioral: Directive Counseling (DC)
Sponsors: Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Bloomberg School of Public Health; National Institute on Deafness and Other Communication Disorders (NIDCD); University of Alabama, Tuscaloosa; David Grant U.S. Air Force Medical Center; Wilford Hall Medical Center; United States Naval Medical Center, San Diego; United States Naval Medical Center, Portsmouth; National Naval Medical Center; Naval Hospital Camp Pendleton
Recruiting - verified February 2012 - Condition: Tinnitus
Interventions: Procedure: Telephone Tinnitus Education; Procedure: Wait List Control
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified December 2011 - Condition: Tinnitus
Interventions: Device: repetitive transcranial magnetic stimulation (rTMS); Device: placebo rTMS
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified January 2012 - Condition: Hearing Loss, Noise-Induced
Interventions: Behavioral: Multimedia hearing loss prevention program; Behavioral: Hearing Conservation brochure
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified February 2012 - Condition: Tinnitus
Interventions: Procedure: Progressive Tinnitus Management; Procedure: Usual Care
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Tinnitus
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS) - ACTIVE; Device: Repetitive Transcranial Magnetic Stimulation (rTMS) - SHAM
Sponsors: University of Arkansas; University of Arkansas; National Institutes of Health (NIH)
Recruiting - verified April 2012 - Condition: Hearing Loss, Sensorineural
Intervention: Behavioral: PC-Based Consonant Discrimination Training
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified April 2012 - Conditions: Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Liver Cancer; Neuroblastoma; Ototoxicity; Ovarian Cancer; Sarcoma
Interventions: Drug: sodium thiosulfate; Procedure: examination
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Neurotoxicity; Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: management of therapy complications
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Conditions: Retinitis Pigmentosa Syndromic; Congenital Deafness; Usher Syndrome; Retinitis Pigmentosa and Deafness; Progressive Hearing Loss; Retinitis Pigmentosa
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified July 2011 - Conditions: Craniosynostosis; Muenke Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2011 - Conditions: Sensorineural Hearing Loss; Hearing Disorder; Vestibular Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified December 2011 - Conditions: Sensorineural Hearing Loss; Cytomegalovirus Infection
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified December 2011
 |
Clinical Trials for Communication Disorders, Hearing |
